www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20250724.pdf

Latest saved version

2026年３月期 第１四半期決算短信〔日本基準〕（連結）

This is the newest public snapshot for this URL and the best place to start reviewing the page.

Source URL

https://www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20250724.pdf

About this page

This document is the consolidated financial results report for the first quarter of the fiscal year ending March 2026, published by Kawachi Pharmaceutical Co., Ltd. on July 24, 2025. It covers the period from March 16, 2025, to June 15, 2025. The report indicates that sales amounted to 71.025 billion yen, a 0.4% decrease compared to the same period last year. Operating profit decreased by 22.2% to 1.249 billion yen, and ordinary profit decreased by 11.5% to 1.611 billion yen. The net profit attributable to the parent company was 1.045 billion yen, also down by 11.5%. Despite a gradual economic recovery, challenges such as rising prices and intensified competition are noted, prompting the company to enhance its health food offerings and review pricing strategies.